Trial Profile
Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer And a Classic Mood Stabilizer for Bipolar Disorder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2022
Price :
$35
*
At a glance
- Drugs Lithium (Primary) ; Quetiapine (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- Acronyms Bipolar CHOICE
- 04 Mar 2022 Results (n=476) published in the Acta Psychiatrica Scandinavica
- 01 Mar 2022 Results from two similar 24-weeks comparative effectiveness trials used to assess cardiometabolic risk markers during mood-stabilizing treatment published in the Journal of Affective Disorders
- 01 Aug 2021 Results published in the Journal of Psychiatric Research